Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by University of Lausanne Hospitals.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
John O. Prior, University of Lausanne Hospitals
ClinicalTrials.gov Identifier:
NCT01434797
First received: September 1, 2011
Last updated: April 16, 2012
Last verified: April 2012
  Purpose

The study hypothesis is that F-18-FDG PET/CT and microcalorimetry might have a diagnostic value in the detection of permanent central venous catheters (PCVC) infection when conventional means of PCVC infection detection are non-conclusive.


Condition
Infection

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Study on the Usefulness and Diagnostic Value of F-18-FDG PET/CT in the Diagnosis of Permanent Central Venous Catheters Infection

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • Diagnostic value (sensitivity and sensibility, positive/negative predictive value) of F-18-FDG PET/CT imaging in the detection of CVCP infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    To determine the clinical use of PET/CT in the detection of catheter infection by comparing PET/CT imaging results to standard means of catheter infection detection (i.e. clinical signs and hemoculture [positive or negative])


Secondary Outcome Measures:
  • Diagnostic value (sensitivity and sensibility, positive/negative predictive value) of microcalorimetry in the detection of CVCP infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    To determine the clinical use of microcalorimetry in the detection of catheter infection by comparing microcalorimetry results to standard means of catheter infection detection (i.e. clinical signs and hemoculture [positive or negative])


Estimated Enrollment: 40
Study Start Date: September 2011
Estimated Study Completion Date: February 2013
Groups/Cohorts
Confirmed CVCP infection before removal
Patients with permanent central venous catheter infection confirmed by conventional method
Presumed CPVP infection before removal
Patients with probable permanent central venous catheter infection (standard methods for infection detection not conclusive)
Uninfected CVCP before removal
Patients with planned permanent central venous catheter removal (no infection)

Detailed Description:

Permanent central venous catheters are frequently infected and therefore need surgical removal. When a clear diagnostic for infection cannot be defined, catheter removal might be at risk for the patient, for the therapeutic follow-up and in terms of costs. PET/CT and microcalorimetry might help giving conclusive diagnostic of catheter infection.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with pathology requiring permanent central venous catheter will be selected mainly from nephrology and oncology departments . They might also be selected from other deparments.

Criteria

Inclusion Criteria:

  • patients with confirmed catheter infection requiring surgical removal
  • patients with probable catheter infection requiring surgical removal
  • patients with planned removal of uninfected catheter
  • ≥18years old

Exclusion Criteria:

  • extreme claustrophobia
  • pregnancy and breastfeeding
  • severe septicemia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01434797

Contacts
Contact: John O Prior, PhD MD +41 21 314 43 48 john.prior@chuv.ch

Locations
Switzerland
Centre Hospitalier Universitaire Vaudois, Nuclear Medicine Recruiting
Lausanne, Vaud, Switzerland, 1011
Sub-Investigator: François Saucy, MD         
Sub-Investigator: Andrej Trampuz, MD         
Sponsors and Collaborators
University of Lausanne Hospitals
Investigators
Principal Investigator: John O Prior, PhD MD Centre Hospitalier Universitaire Vaudois and University of Lausanne
  More Information

No publications provided

Responsible Party: John O. Prior, Centre Hospitalier Universitaire Vaudois, Nuclear Medicine, University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT01434797     History of Changes
Other Study ID Numbers: 89/11
Study First Received: September 1, 2011
Last Updated: April 16, 2012
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Lausanne Hospitals:
Infection
Permanent central venous catheter
Device Related

Additional relevant MeSH terms:
Infection
Communicable Diseases

ClinicalTrials.gov processed this record on October 16, 2014